BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9379039)

  • 1. Rigidification of the alpha2 helix of an MHC class I molecule by a valine to proline mutation in position 165 does not prevent peptide-specific antigen presentation.
    Plaksin D; Polakova K; Mage MG; Margulies DH
    J Immunol; 1997 Nov; 159(9):4408-14. PubMed ID: 9379039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism at position nine of the MHC class I heavy chain affects the stability of association with beta 2-microglobulin and presentation of a viral peptide.
    Ribaudo RK; Margulies DH
    J Immunol; 1995 Oct; 155(7):3481-93. PubMed ID: 7561043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional cell surface expression by a recombinant single-chain class I major histocompatibility complex molecule with a cis-active beta 2-microglobulin domain.
    Lee L; McHugh L; Ribaudo RK; Kozlowski S; Margulies DH; Mage MG
    Eur J Immunol; 1994 Nov; 24(11):2633-9. PubMed ID: 7957555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH dependence of MHC class I-restricted peptide presentation.
    Stryhn A; Pedersen LO; Romme T; Olsen AC; Nissen MH; Thorpe CJ; Buus S
    J Immunol; 1996 Jun; 156(11):4191-7. PubMed ID: 8666787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC class I antigen presentation--recently trimmed and well presented.
    Flutter B; Gao B
    Cell Mol Immunol; 2004 Feb; 1(1):22-30. PubMed ID: 16212917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the interactions between MHC class I subunits: a systematic approach for the engineering of higher affinity variants of beta 2-microglobulin.
    Shields MJ; Assefi N; Hodgson W; Kim EJ; Ribaudo RK
    J Immunol; 1998 Mar; 160(5):2297-307. PubMed ID: 9498770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.
    Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y
    J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-canonical anchor motif peptides bound to MHC class I induce cellular responses.
    Lazoura E; Lodding J; Farrugia W; Day S; Ramsland PA; Apostolopoulos V
    Mol Immunol; 2009 Mar; 46(6):1171-8. PubMed ID: 19118903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of MHC class I molecules with bound peptide antigens.
    Wilson IA; Fremont DH
    Semin Immunol; 1993 Apr; 5(2):75-80. PubMed ID: 8504218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC class I molecules, structure and function.
    Natarajan K; Li H; Mariuzza RA; Margulies DH
    Rev Immunogenet; 1999; 1(1):32-46. PubMed ID: 11256571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
    Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
    Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides.
    Wang W; Man S; Gulden PH; Hunt DF; Engelhard VH
    J Immunol; 1998 Feb; 160(3):1091-7. PubMed ID: 9570521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional structures of MHC class I-peptide complexes: implications for peptide recognition.
    Persson K; Schneider G
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):135-42. PubMed ID: 10912617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How the T cell repertoire becomes peptide and MHC specific.
    Huseby ES; White J; Crawford F; Vass T; Becker D; Pinilla C; Marrack P; Kappler JW
    Cell; 2005 Jul; 122(2):247-60. PubMed ID: 16051149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative aspects of T cell activation--peptide generation and editing by MHC class I molecules.
    Stevanović S; Schild H
    Semin Immunol; 1999 Dec; 11(6):375-84. PubMed ID: 10625591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.
    Martayan A; Sibilio L; Tremante E; Lo Monaco E; Mulder A; Fruci D; Cova A; Rivoltini L; Giacomini P
    J Immunol; 2009 Mar; 182(6):3609-17. PubMed ID: 19265139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of conserved glycosylation site unique to murine class I MHC in recognition by Ly-49 NK cell receptor.
    Lian RH; Freeman JD; Mager DL; Takei F
    J Immunol; 1998 Sep; 161(5):2301-6. PubMed ID: 9725224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.